|
| Press Releases |
|
 |
|
| Thursday, August 17, 2023 |
|
|
Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics |
| Driving towards its goal of continued global growth in the surgical robotics sector, Asensus Surgical (NYSE American: ASXC) provided a positive update on both recent accomplishments and the company's projected outlook for the coming year. more info >> |
|
| Tuesday, June 13, 2023 |
|
|
Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders |
| PCG Digital--Lipella Pharmaceuticals (Nasdaq: LIPO) is a clinical-stage biotechnology company addressing serious diseases with significant unmet medical need and potentially changing the lives of countless cancer survivors. more info >> |
|
| Thursday, June 1, 2023 |
|
|
Asensus Shares First Quarter Results and Future Plans |
| PCG Digital -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery(TM), recently shared notable operating and financial results for Q1 2023 and significant plans moving forward. more info >> |
|
| Monday, January 16, 2023 |
|
|
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024 |
| PCG Digital -- Late-stage biopharmaceutical company, Soligenix, Inc. (Nasdaq: SNGX) is on track to deliver a safe and effective front-line treatment to a community of patients living with rare, chronic cancer. more info >> |
|
| Tuesday, August 9, 2022 |
|
|
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans |
| The development-stage biotech Virios Therapeutics, Inc. (Nasdaq:VIRI) is anticipating the reporting of phase 2b treatment results for its lead fibromyalgia treatment candidate this September and continues to add value through its research and development of compelling clinical assets for multiple categories of viruses. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
邁威生物衝刺港股 國產Nectin-4 ADC領跑者蓄勢待發
Apr 20, 2026 16:38 HKT/SGT
|
|
|
迈威生物冲刺港股 国产Nectin-4 ADC领跑者蓄势待发
Apr 20, 2026 16:28 HKT/SGT
|
|
|
From the Heart: Discover Taiwan's 19 Hot Spring Regions and Embark on Asia's Most Restorative Mountain and Coastal Spa Journey
Apr 20, 2026 15:00: JST
|
|
|
邁威生物啟動港股招股：研發創新為核心 多元化管線佈局打造長期增長曲線
Apr 20, 2026 14:29 HKT/SGT
|
|
|
迈威生物启动港股招股：研发创新为核心 多元化管线布局打造长期增长曲线
Apr 20, 2026 14:29 HKT/SGT
|
|
|
東方證券與上海證券籌劃合併重組 加快推進一流現代投資銀行建設
Apr 20, 2026 14:19 HKT/SGT
|
|
|
From the Heart: Discover Taiwan's 19 Hot Spring Regions and Embark on Asia's Most Restorative Mountain and Coastal Spa Journey
Apr 20, 2026 14:00 HKT/SGT
|
|
|
華大北斗亮相2026「飛向深空」航天大會 展望低軌衛星通導芯片新機遇
Apr 20, 2026 12:25 HKT/SGT
|
|
|
华大北斗亮相2026“飞向深空”航天大会 展望低轨卫星通导芯片新机遇
Apr 20, 2026 12:03 HKT/SGT
|
|
|
洲際船務（2409.HK）雙輪驅動抗週期 業績逆勢增長可期
Apr 20, 2026 11:17 HKT/SGT
|
|
|
邁威生物赴港上市：核心ADC產品臨床領先 國際化佈局提速
Apr 20, 2026 11:04 HKT/SGT
|
|
|
三菱重工、豪州政府と次期汎用フリゲートの共同開発・生産に関する契約締結
Apr 20, 2026 11:00: JST
|
|
|
迈威生物赴港上市：核心ADC产品临床领先 国际化布局提速
Apr 20, 2026 10:59 HKT/SGT
|
|
|
富士通、中堅民需向けERPソリューション「GLOVIA One」を提供開始
Apr 20, 2026 10:20: JST
|
|
|
NEC to Supply Nine Types of Defense Equipment for Tthree Australian Frigates
Apr 19, 2026 12:10 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
